ERCC polymorphisms and prognosis of patients with osteosarcoma

ERCC1 mRNA Expression as a Postoperative Prognostic Marker in Extrahepatic Bile Duct Cancer

(2014) Shuichiro Uemura et al.   ANNALS OF SURGICAL ONCOLOGY

Laryngeal cancer risk and common single nucleotide polymorphisms in nucleotide excision repair pathway genes ERCC1, ERCC2, ERCC3, ERCC4, ERCC5 and XPA

(2014) Baocai Lu et al.   GENE

Association of ERCC1 C8092A and ERCC2 Lys751Gln Polymorphisms with the Risk of Glioma: A Meta-Analysis

(2014) Yu Xin et al.   PLoS One

Complex association between ERCC2 gene polymorphisms, gender, smoking and the susceptibility to bladder cancer: a meta-analysis

(2014) Yuanyi Wu et al.   TUMOR BIOLOGY

Association of ERCC1 and ERCC2 polymorphisms with colorectal cancer risk in a Chinese population

(2014) Min Ni et al.   Scientific Reports

Glutathione S-transferase P1 and DNA Polymorphisms with the Response to Chemotherapy and the Prognosis of Bone Tumor

(2013) Li-Min Yang et al.   Asian Pacific Journal of Cancer Prevention

Association of Four ERCC1 and ERCC2 SNPs with Survival of Bone Tumour Patients

(2013) Ting Hao et al.   Asian Pacific Journal of Cancer Prevention

Predictive Impact of Common Variations in DNA Repair Genes on Clinical Outcome of Osteosarcoma

(2013) Sheng-Bin Bai et al.   Asian Pacific Journal of Cancer Prevention

Single Nucleotide Polymorphisms in the NER Pathway and Clinical Outcome of Patients with Bone Malignant Tumor

(2013) Xiao-Hui Sun et al.   Asian Pacific Journal of Cancer Prevention

Novel Oxidatively Activated Agents Modify DNA and Are Enhanced by Ercc1 Silencing

(2012) Amy R. Jones et al.   CHEMICAL RESEARCH IN TOXICOLOGY

Nucleotide excision repair gene variants and association with survival in osteosarcoma patients treated with neoadjuvant chemotherapy

(2011) P Biason et al.   PHARMACOGENOMICS JOURNAL

Critical evaluation of the Newcastle-Ottawa scale for the assessment of the quality of nonrandomized studies in meta-analyses

(2010) Andreas Stang   EUROPEAN JOURNAL OF EPIDEMIOLOGY

Common variations in ERCC2 are associated with response to cisplatin chemotherapy and clinical outcome in osteosarcoma patients

(2009) D Caronia et al.   PHARMACOGENOMICS JOURNAL